Pretzel Therapeutics
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $72.5M
Overview
A biotech developing therapies for rare diseases by targeting mitochondrial biology and genetics.
Rare DiseaseMetabolic DisordersNeurology
Technology Platform
A platform focused on mitochondrial biology, developing gene therapies and small molecules to correct dysfunction by targeting the mitochondrial and nuclear genomes.
Funding History
1Total raised:$72.5M
Venture$72.5M
Opportunities
Potential to create transformative treatments for rare mitochondrial diseases, a area with high unmet need and often clear genetic causes.
Risk Factors
Significant technical risks related to delivery, potency, and potential toxicity of therapies targeting fundamental cellular organelles.
Competitive Landscape
Operates in the specialized mitochondrial medicine space, competing with a small number of biotechs like Reneo Pharmaceuticals and Minovia Therapeutics.